他克莫司胶囊0.5mg&1mg（一致性评价）引入302车间二楼生产线的

Tacrolimus capsules 0.5mg & 1mg (Evaluation of consistency) introduced changes (subsequent process) 302 workshop floor production line: <br>1. Project the "drafting tacrolimus capsules 0.5mg (Evaluation of consistency) process validation scheme, process planning, batch records "completion time to adjust to 2020.08.31. <br>2. plans to "complete Tacrolimus Capsules 1mg (conformance evaluation) process validation reports, cleaning confirmation report" completion time postponed to 2020.04; "complete Tacrolimus Capsules 0.5mg (conformance evaluation) process validation report, clean confirmation report "completion time to adjust to 2021.02.28. "

Takermoss capsule0.5mg s 1mg (conformity evaluation) introduced 302 workshop second floor production line changes (follow-up processing):<br>1. The completion time of "drafting 0.5mg (conformity evaluation) process verification program, process procedure and batch record is adjusted to 2020.08.31.<br>2. It is planned to extend the completion time of "Complete taquemos capsule 1mg (consistency evaluation) process verification report and cleaning confirmation report" to 2020.04, and "complete tamcus capsule 0.5mg (consistency evaluation) process verification report, cleaning confirmation report" completion time to 2021.02.28. "

The change of tacrolimus capsule 0.5mg-1mg (consistency evaluation) introduced into the second floor production line of workshop 302 (follow-up treatment):<br>1. It is planned to adjust the completion time of "drafting process validation scheme, process procedure and batch record of tacrolimus 0.5mg (consistency evaluation)" to 2020.08.31.<br>2. It is planned to postpone the completion time of "1mg process validation report and cleaning validation report of tacrolimus capsule" to 2020.04; "0.5mg process validation report and cleaning validation report of tacrolimus capsule" to 2021.02.28. "<br>